CG Oncology, Inc. (CGON) Balance Sheet
As of 2026-06-30 (10-Q), CG Oncology, Inc. (CGON) reported total assets of $1.1B, total liabilities of $56.5M and shareholders' equity of $1.0B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $19.6M. Long-term debt: $3.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGONCG Oncology, Inc.Follow CGON — free
—
Price chart with a free account
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|
| Cash and equivalents | 0.26 | 0.03 | 0.02 | |
| Short-term investments | 0.48 | 0.71 | 1.01 | |
| Receivables | 0.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | |
| Current assets | 0.75 | 0.76 | 1.05 | |
| Total assets | 0.75 | 0.79 | 1.09 | |
| Current liabilities | 0.02 | 0.03 | 0.05 | |
| Long-term debt | 0.00 | 0.00 | 0.00 | |
| Total liabilities | 0.02 | 0.04 | 0.06 | |
| Shareholders' equity | 0.73 | 0.75 | 1.03 |
USD billions · SEC XBRL
CG Oncology, Inc. — questions
- How much cash does CG Oncology, Inc. have?
- $19.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does CG Oncology, Inc. have?
- $3.0M of long-term debt as of 2026-06-30.
- What are CG Oncology, Inc.'s total assets?
- $1.1B as of 2026-06-30.
- What is CG Oncology, Inc.'s shareholders' equity?
- $1.0B as of 2026-06-30.
Every figure on this page comes from CG Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.